South Korea Regulator Orders Up To 1,000 Drugs Pulled For Asbestos
This article was originally published in PharmAsia News
Executive Summary
South Korea's FDA has ordered drug makers, pharmacies and others to trash an estimated 1,000 drugs and medical products containing talc or talcum powders feared to contain asbestos. The names of the products suspected of being contaminated were not yet disclosed. A scare of contamination began with 11 brands of baby powder, but later an estimated 1,000 drugs were known to contain the widely used talc, a key ingredient in making pills, particularly capsules. The Central Pharmaceutical Affairs Review Committee is set to advise the KFDA on which drugs to pull from the market. (Click here for more
You may also be interested in...
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.